TrialRheumatology (Oxford, England)2026

Whole body-MRI identifies widespread, low intensity inflammation in peripheral joints, and axial involvement in a third of patients with early, treatment-naïve, active PsA: data from the GOLMePsA clinical trial.

Gabriele De Marco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.